{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:07:19Z","timestamp":1789020439243,"version":"build-2803163510"},"reference-count":82,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T00:00:00Z","timestamp":1692316800000},"content-version":"vor","delay-in-days":382,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005595","name":"University of California","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009858","name":"Gabrielle's Angel Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DP2 OD022552"],"award-info":[{"award-number":["DP2 OD022552"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["F32CA236156"],"award-info":[{"award-number":["F32CA236156"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K08 CA184116"],"award-info":[{"award-number":["K08 CA184116"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 CA082103"],"award-info":[{"award-number":["P30 CA082103"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DoD PC180716"],"award-info":[{"award-number":["DoD PC180716"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA226851"],"award-info":[{"award-number":["R01 CA226851"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NS059690"],"award-info":[{"award-number":["R01 NS059690"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001253","name":"Multiple Myeloma Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001253","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Chemical Biology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.chembiol.2022.06.010","type":"journal-article","created":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T10:42:44Z","timestamp":1658140964000},"page":"1288-1302.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Allosteric HSP70 inhibitors perturb mitochondrial proteostasis and overcome proteasome inhibitor resistance in multiple myeloma"],"prefix":"10.1016","volume":"29","author":[{"given":"Ian D.","family":"Ferguson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Hsiu T.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M.","family":"Tharp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Hale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corynn","family":"Kasap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarette C.","family":"Mariano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Kishishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonell","family":"Pati\u00f1o Escobar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Mandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Steri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Phojanakong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami T.","family":"Tuomivaara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byron","family":"Hann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Driessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Van Ness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason E.","family":"Gestwicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun P.","family":"Wiita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chembiol.2022.06.010_bib1","doi-asserted-by":"crossref","first-page":"e08153","DOI":"10.7554\/eLife.08153","article-title":"Paradoxical resistance of multiple myeloma to proteasome inhibitors by decreased levels of 19S proteasomal subunits","volume":"4","author":"Acosta-Alvear","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.chembiol.2022.06.010_bib2","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.ccell.2015.10.002","article-title":"Targeting the AAA ATPase p97 as an approach to treat cancer through disruption of protein homeostasis","volume":"28","author":"Anderson","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.chembiol.2022.06.010_bib3","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"Barretina","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2022.06.010_bib4","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s41375-018-0216-8","article-title":"Spectrum and functional validation of PSMB5 mutations in multiple myeloma","volume":"33","author":"Barrio","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.chembiol.2022.06.010_bib5","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/leu.2017.212","article-title":"Carfilzomib resistance due to ABCB1\/MDR1 overexpression is overcome by nelfinavir and lopinavir in multiple myeloma","volume":"32","author":"Besse","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.chembiol.2022.06.010_bib6","doi-asserted-by":"crossref","first-page":"e415","DOI":"10.3324\/haematol.2018.207704","article-title":"A metabolic switch in proteasome inhibitor-resistant multiple myeloma ensures higher mitochondrial metabolism, protein folding and sphingomyelin synthesis","volume":"104","author":"Besse","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.chembiol.2022.06.010_bib7","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1089\/ars.2013.5305","article-title":"MnSOD in oxidative stress response-potential regulation via mitochondrial protein influx","volume":"20","author":"Candas","year":"2014","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.chembiol.2022.06.010_bib8","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/bjh.13304","article-title":"Targeted inhibition of the deubiquitinating enzymes, USP14 and UCHL5, induces proteotoxic stress and apoptosis in Waldenstrom macroglobulinaemia tumour cells","volume":"169","author":"Chitta","year":"2015","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.chembiol.2022.06.010_bib9","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.1158\/1078-0432.CCR-16-2692","article-title":"Blockade of deubiquitylating enzyme USP1 inhibits DNA repair and triggers apoptosis in multiple myeloma cells","volume":"23","author":"Das","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.chembiol.2022.06.010_bib10","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1038\/s41467-019-11594-y","article-title":"Hsp70 and Hsp40 inhibit an inter-domain interaction necessary for transcriptional activity in the androgen receptor","volume":"10","author":"Eftekharzadeh","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chembiol.2022.06.010_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00280-001-0380-8","article-title":"Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 rats","volume":"49","author":"Egorin","year":"2002","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.chembiol.2022.06.010_bib12","doi-asserted-by":"crossref","first-page":"114698","DOI":"10.18632\/oncotarget.22815","article-title":"Proteasome and heat shock protein 70 (HSP70) inhibitors as therapeutic alternative in multiple myeloma","volume":"8","author":"Eugenio","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.chembiol.2022.06.010_bib13","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fendo.2018.00218","article-title":"Soluble and cell-cell-mediated drivers of proteasome inhibitor resistance in multiple myeloma","volume":"9","author":"Farrell","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.chembiol.2022.06.010_bib14","doi-asserted-by":"crossref","first-page":"13115","DOI":"10.1074\/jbc.M115.637595","article-title":"Isoform-selective genetic inhibition of constitutive cytosolic Hsp70 activity promotes client Tau degradation using an altered Co-chaperone complement","volume":"290","author":"Fontaine","year":"2015","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2022.06.010_bib15","doi-asserted-by":"crossref","first-page":"5926","DOI":"10.1158\/0008-5472.CAN-16-0800","article-title":"Anticancer effects of targeting Hsp70 in tumor stromal cells","volume":"76","author":"Gabai","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.chembiol.2022.06.010_bib16","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41586-020-2078-2","article-title":"Mitochondrial stress is relayed to the cytosol by an OMA1-DELE1-HRI pathway","volume":"579","author":"Guo","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2022.06.010_bib17","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1038\/s41467-020-15521-4","article-title":"Proteasome inhibitor-induced modulation reveals the spliceosome as a specific therapeutic vulnerability in multiple myeloma","volume":"11","author":"Huang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chembiol.2022.06.010_bib18","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s12192-020-01078-0","article-title":"Blockade of HSP70 by VER-155008 synergistically enhances bortezomib-induced cytotoxicity in multiple myeloma","volume":"25","author":"Huang","year":"2020","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.chembiol.2022.06.010_bib19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/978-3-030-40204-4_10","article-title":"Lessons learned from proteasome inhibitors, the paradigm for targeting protein homeostasis in cancer","volume":"1243","author":"Kambhampati","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.chembiol.2022.06.010_bib20","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.3317","article-title":"HISAT: a fast spliced aligner with low memory requirements","volume":"12","author":"Kim","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.chembiol.2022.06.010_bib21","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.3324\/haematol.2017.174482","article-title":"Repurposing tofacitinib as an anti-myeloma therapeutic to reverse growth-promoting effects of the bone marrow microenvironment","volume":"103","author":"Lam","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.chembiol.2022.06.010_bib22","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.chembiol.2022.06.010_bib23","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1158\/1535-7163.MCT-17-0233","article-title":"The p97 inhibitor CB-5083 is a unique disrupter of protein homeostasis in models of Multiple Myeloma","volume":"16","author":"Le Moigne","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.chembiol.2022.06.010_bib83","doi-asserted-by":"crossref","first-page":"45656","DOI":"10.18632\/oncotarget.17321","article-title":"Inhibition of stress-inducible HSP70 impairs mitochondrial proteostasis and function","volume":"8","author":"Leu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.chembiol.2022.06.010_bib24","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ccr.2013.08.009","article-title":"Xbp1s-negative tumor B cells and pre-plasmablasts mediate therapeutic proteasome inhibitor resistance in multiple myeloma","volume":"24","author":"Leung-Hagesteijn","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.chembiol.2022.06.010_bib25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/1471-2105-12-323","article-title":"RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome","volume":"12","author":"Li","year":"2011","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.chembiol.2022.06.010_bib26","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1158\/1535-7163.MCT-14-0650","article-title":"Validation of the Hsp70-Bag3 protein-protein interaction as a potential therapeutic target in cancer","volume":"14","author":"Li","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.chembiol.2022.06.010_bib27","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1021\/ml400204n","article-title":"Analogs of the Allosteric Heat Shock Protein 70 (Hsp70) Inhibitor, MKT-077, as Anti-Cancer Agents","volume":"4","author":"Li","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.chembiol.2022.06.010_bib28","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.chembiol.2022.06.010_bib29","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nrclinonc.2016.206","article-title":"Proteasome inhibitors in cancer therapy","volume":"14","author":"Manasanch","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.chembiol.2022.06.010_bib30","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1101\/gad.1250704","article-title":"CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum","volume":"18","author":"Marciniak","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.chembiol.2022.06.010_bib31","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.1182\/bloodadvances.2020002711","article-title":"Quantitative expression of Ikaros, IRF4, and PSMD10 proteins predicts survival in VRD-treated patients with multiple myeloma","volume":"4","author":"Misiewicz-Krzeminska","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.chembiol.2022.06.010_bib32","doi-asserted-by":"crossref","first-page":"e581","DOI":"10.1038\/bcj.2017.56","article-title":"A gene expression signature distinguishes innate response and resistance to proteasome inhibitors in multiple myeloma","volume":"7","author":"Mitra","year":"2017","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.chembiol.2022.06.010_bib33","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/leu.2015.361","article-title":"Single-cell analysis of targeted transcriptome predicts drug sensitivity of single cells within human myeloma tumors","volume":"30","author":"Mitra","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.chembiol.2022.06.010_bib34","doi-asserted-by":"crossref","first-page":"14374","DOI":"10.1073\/pnas.202445099","article-title":"Molecular sequelae of proteasome inhibition in human multiple myeloma cells","volume":"99","author":"Mitsiades","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U\u00a0S\u00a0A"},{"key":"10.1016\/j.chembiol.2022.06.010_bib35","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1021\/cn300210g","article-title":"Synthesis and initial evaluation of YM-08, a blood-brain barrier permeable derivative of the heat shock protein 70 (Hsp70) inhibitor MKT-077, which reduces tau levels","volume":"4","author":"Miyata","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.chembiol.2022.06.010_bib36","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0169-409X(01)00125-9","article-title":"Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells","volume":"49","author":"Modica-Napolitano","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.chembiol.2022.06.010_bib37","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1158\/0008-5472.CAN-17-3728","article-title":"Targeting the Hsp40\/Hsp70 chaperone Axis as a novel strategy to treat castration-resistant prostate cancer","volume":"78","author":"Moses","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.chembiol.2022.06.010_bib38","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1182\/blood-2006-09-044974","article-title":"Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib","volume":"109","author":"Mulligan","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.chembiol.2022.06.010_bib39","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/jclinpath-2015-203414","article-title":"Molecular mechanisms in multiple myeloma drug resistance","volume":"69","author":"Nikesitch","year":"2016","journal-title":"J.\u00a0Clin. Pathol."},{"key":"10.1016\/j.chembiol.2022.06.010_bib40","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1182\/blood-2005-08-3531","article-title":"Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells","volume":"107","author":"Obeng","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.chembiol.2022.06.010_bib41","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.15252\/embr.201642195","article-title":"The integrated stress response","volume":"17","author":"Pakos-Zebrucka","year":"2016","journal-title":"EMBO Rep."},{"key":"10.1016\/j.chembiol.2022.06.010_bib42","doi-asserted-by":"crossref","first-page":"e430","DOI":"10.1038\/cddis.2012.171","article-title":"JC-1: alternative excitation wavelengths facilitate mitochondrial membrane potential cytometry","volume":"3","author":"Perelman","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.chembiol.2022.06.010_bib43","doi-asserted-by":"crossref","first-page":"D442","DOI":"10.1093\/nar\/gky1106","article-title":"The PRIDE database and related tools and resources in 2019: improving support for quantification data","volume":"47","author":"Perez-Riverol","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.chembiol.2022.06.010_bib44","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1182\/bloodadvances.2019001346","article-title":"CRISPR-based screens uncover determinants of immunotherapy response in multiple myeloma","volume":"4","author":"Ramkumar","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.chembiol.2022.06.010_bib45","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1182\/bloodadvances.2019001346","article-title":"CRISPR-based screens uncover determinants of immunotherapy response in multiple myeloma","volume":"4","author":"Ramkumar","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.chembiol.2022.06.010_bib47","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41580-019-0133-3","article-title":"The Hsp70 chaperone network","volume":"20","author":"Rosenzweig","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.chembiol.2022.06.010_bib48","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jmb.2011.06.003","article-title":"Allosteric drugs: the interaction of antitumor compound MKT-077 with human Hsp70 chaperones","volume":"411","author":"Rousaki","year":"2011","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.chembiol.2022.06.010_bib49","doi-asserted-by":"crossref","first-page":"20119","DOI":"10.18632\/oncotarget.24614","article-title":"Mouse models of multiple myeloma: technologic platforms and perspectives","volume":"9","author":"Rossi","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.chembiol.2022.06.010_bib50","doi-asserted-by":"crossref","first-page":"9015","DOI":"10.1073\/pnas.1603883113","article-title":"Combined chemical-genetic approach identifies cytosolic HSP70 dependence in rhabdomyosarcoma","volume":"113","author":"Sabnis","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2022.06.010_bib51","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.cell.2018.02.030","article-title":"Multiplexed proteome dynamics profiling reveals mechanisms controlling protein homeostasis","volume":"173","author":"Savitski","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.chembiol.2022.06.010_bib52","doi-asserted-by":"crossref","first-page":"e78443","DOI":"10.1371\/journal.pone.0078443","article-title":"Functional analysis of Hsp70 inhibitors","volume":"8","author":"Schlecht","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.chembiol.2022.06.010_bib53","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1158\/1541-7786.MCR-15-0135","article-title":"When cancer fights back: multiple myeloma, proteasome inhibition, and the heat-shock response","volume":"13","author":"Shah","year":"2015","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.chembiol.2022.06.010_bib54","doi-asserted-by":"crossref","first-page":"59727","DOI":"10.18632\/oncotarget.10847","article-title":"Bortezomib-induced heat shock response protects multiple myeloma cells and is activated by heat shock factor 1 serine 326 phosphorylation","volume":"7","author":"Shah","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.chembiol.2022.06.010_bib55","doi-asserted-by":"crossref","first-page":"126954","DOI":"10.1016\/j.bmcl.2020.126954","article-title":"Neutral analogs of the heat shock protein 70 (Hsp70) inhibitor, JG-98","volume":"30","author":"Shao","year":"2020","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.chembiol.2022.06.010_bib56","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.1021\/acs.jmedchem.8b00583","article-title":"Exploration of benzothiazole rhodacyanines as allosteric inhibitors of protein-protein interactions with heat shock protein 70 (Hsp70)","volume":"61","author":"Shao","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.chembiol.2022.06.010_bib57","doi-asserted-by":"crossref","first-page":"5728","DOI":"10.1073\/pnas.76.11.5728","article-title":"Estimation of membrane potentials of individual lymphocytes by flow cytometry","volume":"76","author":"Shapiro","year":"1979","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2022.06.010_bib58","doi-asserted-by":"crossref","first-page":"e05033","DOI":"10.7554\/eLife.05033","article-title":"The small molecule ISRIB reverses the effects of eIF2\u03b1 phosphorylation on translation and stress granule assembly","volume":"4","author":"Sidrauski","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.chembiol.2022.06.010_bib59","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1038\/leu.2016.102","article-title":"Proteasome inhibitor-adapted myeloma cells are largely independent from proteasome activity and show complex proteomic changes, in particular in redox and energy metabolism","volume":"30","author":"Soriano","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.chembiol.2022.06.010_bib60","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1158\/1541-7786.MCR-17-0408","article-title":"Heat shock protein 70 (Hsp70) suppresses RIP1-dependent apoptotic and necroptotic cascades","volume":"16","author":"Srinivasan","year":"2018","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.chembiol.2022.06.010_bib61","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2022.06.010_bib62","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.cell.2015.10.046","article-title":"Defining Hsp70 subnetworks in dengue virus replication reveals key vulnerability in flavivirus infection","volume":"163","author":"Taguwa","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.chembiol.2022.06.010_bib63","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1039\/C9SC04284A","article-title":"Tryptophan scanning mutagenesis as a way to mimic the compound-bound state and probe the selectivity of allosteric inhibitors in cells","volume":"11","author":"Taylor","year":"2020","journal-title":"Chem. Sci."},{"key":"10.1016\/j.chembiol.2022.06.010_bib64","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.neuron.2019.07.014","article-title":"CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons","volume":"104","author":"Tian","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.chembiol.2022.06.010_bib65","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1182\/blood-2013-05-500033","article-title":"A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance","volume":"123","author":"Tian","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.chembiol.2022.06.010_bib66","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.cell.2017.06.010","article-title":"Defining a cancer dependency Map","volume":"170","author":"Tsherniak","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.chembiol.2022.06.010_bib67","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41589-019-0291-9","article-title":"Mitochondrial metabolism promotes adaptation to proteotoxic stress","volume":"15","author":"Tsvetkov","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.chembiol.2022.06.010_bib68","doi-asserted-by":"crossref","first-page":"e08467","DOI":"10.7554\/eLife.08467","article-title":"Compromising the 19S proteasome complex protects cells from reduced flux through the proteasome","volume":"4","author":"Tsvetkov","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.chembiol.2022.06.010_bib69","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1038\/nprot.2016.136","article-title":"The MaxQuant computational platform for mass spectrometry-based shotgun proteomics","volume":"11","author":"Tyanova","year":"2016","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.chembiol.2022.06.010_bib70","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nmeth.3901","article-title":"The Perseus computational platform for comprehensive analysis of (prote)omics data","volume":"13","author":"Tyanova","year":"2016","journal-title":"Nat. Methods"},{"key":"10.1016\/j.chembiol.2022.06.010_bib71","doi-asserted-by":"crossref","first-page":"253","DOI":"10.15698\/cst2018.10.158","article-title":"Mitochondrial stress management: a dynamic journey","volume":"2","author":"Valera-Alberni","year":"2018","journal-title":"Cell Stress"},{"key":"10.1016\/j.chembiol.2022.06.010_bib72","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1158\/1535-7163.MCT-12-0782","article-title":"Endoplasmic reticulum stress and the unfolded protein response: targeting the Achilles heel of multiple myeloma","volume":"12","author":"Vincenz","year":"2013","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.chembiol.2022.06.010_bib73","first-page":"6818","article-title":"Selective toxicity of MKT-077 to cancer cells is mediated by its binding to the hsp70 family protein mot-2 and reactivation of p53 function","volume":"60","author":"Wadhwa","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.chembiol.2022.06.010_bib74","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1126\/science.1209038","article-title":"The unfolded protein response: from stress pathway to homeostatic regulation","volume":"334","author":"Walter","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2022.06.010_bib75","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1074\/mcp.M116.063230","article-title":"Time-resolved analysis of proteome dynamics by tandem mass tags and stable Isotope labeling in cell culture (TMT-SILAC) Hyperplexing","volume":"15","author":"Welle","year":"2016","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.chembiol.2022.06.010_bib76","doi-asserted-by":"crossref","first-page":"e01236","DOI":"10.7554\/eLife.01236","article-title":"Global cellular response to chemotherapy-induced apoptosis","volume":"2","author":"Wiita","year":"2013","journal-title":"Elife"},{"key":"10.1016\/j.chembiol.2022.06.010_bib77","doi-asserted-by":"crossref","first-page":"eaay1478","DOI":"10.1126\/scisignal.aay1478","article-title":"Mortalin (HSPA9) facilitates BRAF-mutant tumor cell survival by suppressing ANT3-mediated mitochondrial membrane permeability","volume":"13","author":"Wu","year":"2020","journal-title":"Sci. Signal."},{"key":"10.1016\/j.chembiol.2022.06.010_bib78","doi-asserted-by":"crossref","first-page":"e0225532","DOI":"10.1371\/journal.pone.0225532","article-title":"Improved chemotherapy modeling with RAG-based immune deficient mice","volume":"14","author":"Wunderlich","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.chembiol.2022.06.010_bib79","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.csbj.2015.09.001","article-title":"Searching for drug synergy in complex dose-response landscapes using an interaction potency model","volume":"13","author":"Yadav","year":"2015","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.chembiol.2022.06.010_bib80","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1038\/s41598-017-14900-0","article-title":"Cancer cell responses to Hsp70 inhibitor JG-98: comparison with Hsp90 inhibitors and finding synergistic drug combinations","volume":"8","author":"Yaglom","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.chembiol.2022.06.010_bib82","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.chembiol.2016.04.014","article-title":"Stabilizing the Hsp70-Tau complex promotes turnover in models of tauopathy","volume":"23","author":"Young","year":"2016","journal-title":"Cell Chem Biol."},{"key":"10.1016\/j.chembiol.2022.06.010_bib81","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1074\/mcp.TIR119.001385","article-title":"TMT labeling for the masses: a robust and cost-efficient, in-solution labeling approach","volume":"18","author":"Zecha","year":"2019","journal-title":"Mol. Cell. Proteomics"}],"container-title":["Cell Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945622002422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945622002422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T14:42:13Z","timestamp":1762526533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451945622002422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":82,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S2451945622002422"],"URL":"https:\/\/doi.org\/10.1016\/j.chembiol.2022.06.010","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.04.21.052456","asserted-by":"object"}]},"ISSN":["2451-9456"],"issn-type":[{"value":"2451-9456","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Allosteric HSP70 inhibitors perturb mitochondrial proteostasis and overcome proteasome inhibitor resistance in multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Cell Chemical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chembiol.2022.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}